2023 Q3 Form 10-Q Financial Statement
#000168316823005337 Filed on August 07, 2023
Income Statement
Concept | 2023 Q3 | 2023 Q2 |
---|---|---|
Revenue | $2.984M | $3.858M |
YoY Change | -44.95% | 291.15% |
Cost Of Revenue | $2.987M | $12.63K |
YoY Change | -25.2% | -98.47% |
Gross Profit | -$2.992K | $3.845M |
YoY Change | -100.21% | 2261.35% |
Gross Profit Margin | -0.1% | 99.67% |
Selling, General & Admin | $116.3K | $1.496M |
YoY Change | -87.02% | 59.61% |
% of Gross Profit | 38.9% | |
Research & Development | $2.703M | $7.653M |
YoY Change | -66.71% | 7464.99% |
% of Gross Profit | 199.01% | |
Depreciation & Amortization | $11.75K | $12.43K |
YoY Change | -1.92% | 2.22% |
% of Gross Profit | 0.32% | |
Operating Expenses | $116.3K | $1.496M |
YoY Change | -87.02% | 59.61% |
Operating Profit | -$2.823M | -$7.154M |
YoY Change | -63.15% | 652.16% |
Interest Expense | $169.5K | -$227.6K |
YoY Change | 1694800.0% | -6894.33% |
% of Operating Profit | ||
Other Income/Expense, Net | $169.4K | -$227.6K |
YoY Change | 1693940.0% | -6902.96% |
Pretax Income | -$2.654M | -$7.382M |
YoY Change | -65.36% | 678.82% |
Income Tax | $0.00 | $0.00 |
% Of Pretax Income | ||
Net Earnings | -$2.654M | -$7.382M |
YoY Change | -65.36% | 681.98% |
Net Earnings / Revenue | -88.92% | -191.34% |
Basic Earnings Per Share | $0.00 | $0.00 |
Diluted Earnings Per Share | $0.00 | $0.00 |
COMMON SHARES | ||
Basic Shares Outstanding | 143.0B shares | 4.554B shares |
Diluted Shares Outstanding | 134.1B shares | 3.097B shares |
Balance Sheet
Concept | 2023 Q3 | 2023 Q2 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $1.072M | $917.5K |
YoY Change | 2612.84% | 39.52% |
Cash & Equivalents | $144.5K | $189.9K |
Short-Term Investments | $927.4K | $727.6K |
Other Short-Term Assets | $10.66K | $10.75K |
YoY Change | -22.78% | -98.3% |
Inventory | $12.03M | $0.00 |
Prepaid Expenses | ||
Receivables | $11.72K | |
Other Receivables | $510.00 | |
Total Short-Term Assets | $16.77M | $4.178M |
YoY Change | 211.9% | -58.06% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | ||
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | $50.60K | $63.26K |
YoY Change | -49.52% | -45.05% |
Long-Term Investments | ||
YoY Change | ||
Other Assets | $168.8K | $199.0K |
YoY Change | ||
Total Long-Term Assets | $219.4K | $262.3K |
YoY Change | 118.84% | 127.85% |
TOTAL ASSETS | ||
Total Short-Term Assets | $16.77M | $4.178M |
Total Long-Term Assets | $219.4K | $262.3K |
Total Assets | $16.99M | $4.441M |
YoY Change | 210.2% | -55.93% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | ||
YoY Change | ||
Accrued Expenses | $24.86M | $11.47M |
YoY Change | 498.18% | 210.27% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $170.0K | $160.0K |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $28.40M | $13.34M |
YoY Change | 292.6% | 219.7% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | ||
YoY Change | ||
Total Long-Term Liabilities | $0.00 | $0.00 |
YoY Change | ||
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $28.40M | $13.34M |
Total Long-Term Liabilities | $0.00 | $0.00 |
Total Liabilities | $28.40M | $13.34M |
YoY Change | 292.6% | 219.7% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$36.76M | -$34.10M |
YoY Change | 42.51% | 88.09% |
Common Stock | $14.31M | $455.4K |
YoY Change | 7564.39% | 143.82% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$11.41M | -$8.895M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $16.99M | $4.441M |
YoY Change | 210.2% | -55.93% |
Cashflow Statement
Concept | 2023 Q3 | 2023 Q2 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$2.654M | -$7.382M |
YoY Change | -65.36% | 681.98% |
Depreciation, Depletion And Amortization | $11.75K | $12.43K |
YoY Change | -1.92% | 2.22% |
Cash From Operating Activities | -$1.760M | -$121.0K |
YoY Change | -1000.29% | 32.54% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $0.00 | $0.00 |
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | $0.00 | $0.00 |
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 1.717M | 244.9K |
YoY Change | -984.43% | 342.32% |
NET CHANGE | ||
Cash From Operating Activities | -1.760M | -121.0K |
Cash From Investing Activities | 0.000 | 0.000 |
Cash From Financing Activities | 1.717M | 244.9K |
Net Change In Cash | -42.59K | 123.9K |
YoY Change | -3351.15% | -445.11% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$1.760M | -$121.0K |
Capital Expenditures | $0.00 | $0.00 |
Free Cash Flow | -$1.760M | -$121.0K |
YoY Change | -1000.29% | 32.54% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001439264 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
CY2022Q2 | us-gaap |
Amortization Of Deferred Charges
AmortizationOfDeferredCharges
|
usd | |
us-gaap |
Amortization Of Deferred Charges
AmortizationOfDeferredCharges
|
usd | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-06-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
000-53612 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
MARVION INC. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
26-2723015 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
21st Floor | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Centennial Tower | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
3 Temasek Avenue | ||
dei |
Entity Address Country
EntityAddressCountry
|
SG | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
039190 | ||
dei |
City Area Code
CityAreaCode
|
65 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
6829 7029 | ||
dei |
Entity Information Former Legal Or Registered Name
EntityInformationFormerLegalOrRegisteredName
|
BONANZA GOLDFIELDS CORP. | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2023Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
143022554520 | shares |
CY2023Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
189852 | usd |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
99274 | usd |
CY2023Q2 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
10746 | usd |
CY2022Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
10203 | usd |
CY2023Q2 | us-gaap |
Inventory Net
InventoryNet
|
0 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
1387500 | usd |
CY2023Q2 | us-gaap |
Short Term Investments
ShortTermInvestments
|
727610 | usd |
CY2022Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
0 | usd |
CY2023Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
3250109 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
3057342 | usd |
CY2023Q2 | us-gaap |
Assets Current
AssetsCurrent
|
4178317 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
4554319 | usd |
CY2023Q2 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
199039 | usd |
CY2022Q4 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
176250 | usd |
CY2023Q2 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
63256 | usd |
CY2022Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
94205 | usd |
CY2023Q2 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
262295 | usd |
CY2022Q4 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
270455 | usd |
CY2023Q2 | us-gaap |
Assets
Assets
|
4440612 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
4824774 | usd |
CY2023Q2 | us-gaap |
Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
|
1601059 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
|
105381 | usd |
CY2023Q2 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
9871937 | usd |
CY2022Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
5172537 | usd |
CY2023Q2 | BONZ |
Amounts Due To Related Parties Current
AmountsDueToRelatedPartiesCurrent
|
1702556 | usd |
CY2022Q4 | BONZ |
Amounts Due To Related Parties Current
AmountsDueToRelatedPartiesCurrent
|
1544729 | usd |
CY2023Q2 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
160000 | usd |
CY2022Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
0 | usd |
CY2023Q2 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
0 | usd |
CY2022Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
1272 | usd |
CY2023Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
13335552 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
6823919 | usd |
CY2023Q2 | us-gaap |
Liabilities
Liabilities
|
13335552 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
6823919 | usd |
CY2023Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
30000000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
30000000000 | shares |
CY2023Q2 | BONZ |
Preferred Stock Shares Undesignated
PreferredStockSharesUndesignated
|
18999999 | shares |
CY2022Q4 | BONZ |
Preferred Stock Shares Undesignated
PreferredStockSharesUndesignated
|
18999999 | shares |
CY2023Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
270000000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
270000000000 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4553837889 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4553837889 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1942681876 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1942681876 | shares |
CY2023Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
455384 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
194268 | usd |
CY2023Q2 | BONZ |
Common Stock To Be Issued Shares
CommonStockToBeIssuedShares
|
138468716631 | shares |
CY2022Q4 | BONZ |
Common Stock To Be Issued Shares
CommonStockToBeIssuedShares
|
140794298026 | shares |
CY2023Q2 | BONZ |
Common Stock To Be Issued
CommonStockToBeIssued
|
13846871 | usd |
CY2022Q4 | BONZ |
Common Stock To Be Issued
CommonStockToBeIssued
|
14079430 | usd |
CY2023Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
10885647 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
9936191 | usd |
CY2023Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
19891 | usd |
CY2022Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-5043 | usd |
CY2023Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-34103771 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-26205029 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-8894940 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1999145 | usd |
CY2023Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4440612 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4824774 | usd |
CY2023Q2 | us-gaap |
Revenues
Revenues
|
3858012 | usd |
CY2022Q2 | us-gaap |
Revenues
Revenues
|
986327 | usd |
us-gaap |
Revenues
Revenues
|
5557710 | usd | |
us-gaap |
Revenues
Revenues
|
1094031 | usd | |
CY2023Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
12626 | usd |
CY2022Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
823480 | usd |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
1414743 | usd | |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
861192 | usd | |
CY2023Q2 | us-gaap |
Gross Profit
GrossProfit
|
3845386 | usd |
CY2022Q2 | us-gaap |
Gross Profit
GrossProfit
|
162847 | usd |
us-gaap |
Gross Profit
GrossProfit
|
4142967 | usd | |
us-gaap |
Gross Profit
GrossProfit
|
232839 | usd | |
CY2023Q2 | us-gaap |
Development Costs
DevelopmentCosts
|
7652739 | usd |
CY2022Q2 | us-gaap |
Development Costs
DevelopmentCosts
|
101162 | usd |
us-gaap |
Development Costs
DevelopmentCosts
|
7786868 | usd | |
us-gaap |
Development Costs
DevelopmentCosts
|
607092 | usd | |
CY2023Q2 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
892340 | usd |
CY2022Q2 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
122510 | usd |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1082989 | usd | |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
189376 | usd | |
CY2023Q2 | us-gaap |
Business Development
BusinessDevelopment
|
1851000 | usd |
CY2022Q2 | us-gaap |
Business Development
BusinessDevelopment
|
72870 | usd |
us-gaap |
Business Development
BusinessDevelopment
|
1896000 | usd | |
us-gaap |
Business Development
BusinessDevelopment
|
132870 | usd | |
CY2023Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
603472 | usd |
CY2022Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
814657 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1048533 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1258663 | usd | |
CY2023Q2 | us-gaap |
Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
|
-23 | usd |
CY2022Q2 | us-gaap |
Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
|
-2803 | usd |
us-gaap |
Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
|
-23 | usd | |
us-gaap |
Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
|
-4049 | usd | |
CY2023Q2 | us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
10999574 | usd |
CY2022Q2 | us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
1114002 | usd |
us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
11814413 | usd | |
us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
2192050 | usd | |
CY2023Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-7154188 | usd |
CY2022Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-951155 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-7671446 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1959211 | usd | |
CY2023Q2 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
0 | usd |
CY2022Q2 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
3345 | usd |
us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
0 | usd | |
us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-18566 | usd | |
CY2023Q2 | us-gaap |
Amortization Of Deferred Charges
AmortizationOfDeferredCharges
|
57611 | usd |
us-gaap |
Amortization Of Deferred Charges
AmortizationOfDeferredCharges
|
57611 | usd | |
CY2023Q2 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
-170003 | usd |
CY2022Q2 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
0 | usd |
us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
-170003 | usd | |
us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
0 | usd | |
CY2023Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
55 | usd |
CY2022Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
0 | usd |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
318 | usd | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
0 | usd | |
CY2023Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-227559 | usd |
CY2022Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
3345 | usd |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-227296 | usd | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-18566 | usd | |
CY2023Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-7381747 | usd |
CY2022Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-947810 | usd |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-7898742 | usd | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-1977777 | usd | |
CY2023Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-0 | usd |
CY2022Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-3823 | usd |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-0 | usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-3823 | usd | |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7381747 | usd |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-943987 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-7898742 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-1973954 | usd | |
CY2023Q2 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
22097 | usd |
CY2022Q2 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
1661 | usd |
us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
24934 | usd | |
us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
2220 | usd | |
CY2023Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-7359650 | usd |
CY2022Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-942326 | usd |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-7873808 | usd | |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-1971734 | usd | |
CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | |
CY2023Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.00 | |
CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
3096783981 | shares |
CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1867681876 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
3096783981 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1867681876 | shares | |
CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
3096783981 | shares |
CY2022Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1867681876 | shares |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
3096783981 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1867681876 | shares | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1999145 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
2837 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-516995 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2513303 | usd |
CY2023Q2 | BONZ |
Shares Issued As Commitment Shares
SharesIssuedAsCommitmentShares
|
80400 | usd |
CY2023Q2 | BONZ |
Shares Issued Under Share Swap Agreement
SharesIssuedUnderShareSwapAgreement
|
897613 | usd |
CY2023Q2 | BONZ |
Shares Issued Under Share Exchange Agreement In Prior Years
SharesIssuedUnderShareExchangeAgreementInPriorYears
|
0 | usd |
CY2023Q2 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
22097 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7381747 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-8894940 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2122683 | usd |
CY2022Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
559 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1029967 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3152091 | usd |
CY2022Q2 | BONZ |
Acquisition Of Licensed Adaptation Right
AcquisitionOfLicensedAdaptationRight
|
10000000 | usd |
CY2022Q2 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
1661 | usd |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-943987 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
5905583 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-7898742 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-1973954 | usd | |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
24992 | usd | |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
24535 | usd | |
us-gaap |
Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
|
57611 | usd | |
us-gaap |
Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
|
0 | usd | |
BONZ |
Written Off Intangible Assets
WrittenOffIntangibleAssets
|
5434 | usd | |
BONZ |
Written Off Intangible Assets
WrittenOffIntangibleAssets
|
0 | usd | |
BONZ |
Digital Assets Received As Revenue
DigitalAssetsReceivedAsRevenue
|
5418542 | usd | |
BONZ |
Digital Assets Received As Revenue
DigitalAssetsReceivedAsRevenue
|
1069272 | usd | |
us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
23 | usd | |
us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
4049 | usd | |
us-gaap |
Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
|
-0 | usd | |
us-gaap |
Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
|
-18566 | usd | |
us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
-170003 | usd | |
us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
-0 | usd | |
us-gaap |
Noncash Or Part Noncash Acquisition Inventory Acquired1
NoncashOrPartNoncashAcquisitionInventoryAcquired1
|
5417972 | usd | |
us-gaap |
Noncash Or Part Noncash Acquisition Inventory Acquired1
NoncashOrPartNoncashAcquisitionInventoryAcquired1
|
802500 | usd | |
us-gaap |
Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
|
-0 | usd | |
us-gaap |
Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
|
-0 | usd | |
us-gaap |
Increase Decrease In Intangible Assets Current
IncreaseDecreaseInIntangibleAssetsCurrent
|
-0 | usd | |
us-gaap |
Increase Decrease In Intangible Assets Current
IncreaseDecreaseInIntangibleAssetsCurrent
|
-513431 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-1387500 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-0 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
193719 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
90505 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1514484 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
139983 | usd | |
BONZ |
Accrued Consulting And Service Fee
AccruedConsultingAndServiceFee
|
4700859 | usd | |
BONZ |
Accrued Consulting And Service Fee
AccruedConsultingAndServiceFee
|
1439535 | usd | |
us-gaap |
Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
|
-1265 | usd | |
us-gaap |
Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
|
-3823 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-233390 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-194955 | usd | |
us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
-0 | usd | |
us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
1886 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1886 | usd | |
us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
160000 | usd | |
us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
0 | usd | |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
162222 | usd | |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
194163 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
322222 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
194163 | usd | |
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1746 | usd | |
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
40 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
90578 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-2638 | usd | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
99274 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
28124 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
189852 | usd |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
25486 | usd |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | usd | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | usd | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd | |
BONZ |
Shares Issued Under Share Swap Agreement In Exchange Of Marketable Securities
SharesIssuedUnderShareSwapAgreementInExchangeOfMarketableSecurities
|
897613 | usd | |
BONZ |
Shares Issued Under Share Swap Agreement In Exchange Of Marketable Securities
SharesIssuedUnderShareSwapAgreementInExchangeOfMarketableSecurities
|
0 | usd | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_844_eus-gaap--UseOfEstimates_ziCnn1hwUWC3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_863_ze7OyIGaVovk">Use of estimates and assumptions</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In preparing these unaudited condensed consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheet and revenues and expenses during the periods reported. Actual results may differ from these estimates. If actual results significantly differ from the Company’s estimates, the Company’s financial condition and results of operations could be materially impacted. Significant estimates in the period include the impairment loss on digital assets, valuation and useful lives of intangible assets and deferred tax valuation allowance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> | ||
CY2023Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
0 | usd |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
0 | usd |
BONZ |
Written Off Intangible Assets
WrittenOffIntangibleAssets
|
5434 | usd | |
BONZ |
Written Off Intangible Assets
WrittenOffIntangibleAssets
|
0 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-7898742 | usd | |
CY2023Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-34103771 | usd |
CY2023Q2 | us-gaap |
Revenues
Revenues
|
3858012 | usd |
CY2022Q2 | us-gaap |
Revenues
Revenues
|
986327 | usd |
us-gaap |
Revenues
Revenues
|
5557710 | usd | |
us-gaap |
Revenues
Revenues
|
1094031 | usd | |
CY2023Q2 | us-gaap |
Revenues
Revenues
|
3858012 | usd |
CY2022Q2 | us-gaap |
Revenues
Revenues
|
986327 | usd |
us-gaap |
Revenues
Revenues
|
5557710 | usd | |
us-gaap |
Revenues
Revenues
|
1094031 | usd | |
CY2023Q2 | us-gaap |
Marketable Securities
MarketableSecurities
|
727610 | usd |
CY2022Q4 | us-gaap |
Marketable Securities
MarketableSecurities
|
0 | usd |
CY2023Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
3250109 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
3057342 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
148712 | usd |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
156502 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
-85456 | usd |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
-62297 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
63256 | usd |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
94205 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
48848 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
|
12444 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
|
310 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
|
310 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Rolling Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive
|
310 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Rolling After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive
|
1034 | usd |
CY2023Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
63256 | usd |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
24992 | usd | |
us-gaap |
Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
|
4699400 | usd | |
us-gaap |
Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
|
1439535 | usd | |
CY2023Q2 | BONZ |
Amounts Due To Related Parties
AmountsDueToRelatedParties
|
1702557 | usd |
CY2022Q4 | BONZ |
Amounts Due To Related Parties
AmountsDueToRelatedParties
|
1544729 | usd |
CY2023Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
30000000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
30000000000 | shares |
CY2023Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
270000000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
270000000000 | shares |
CY2023Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4553837889 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4553837889 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1942681876 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1942681876 | shares |
CY2023Q2 | BONZ |
Common Stock Committed To Be Issued
CommonStockCommittedToBeIssued
|
138468716631 | shares |
CY2022Q4 | BONZ |
Common Stock Committed To Be Issued
CommonStockCommittedToBeIssued
|
140794298026 | shares |
CY2023Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-7381747 | usd |
CY2022Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-943987 | usd |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-7898742 | usd | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1973954 | usd | |
CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
3096783981 | shares |
CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1867681876 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
3096783981 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1867681876 | shares | |
CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
3096783981 | shares |
CY2022Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1867681876 | shares |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
3096783981 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1867681876 | shares | |
CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | |
CY2022Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | ||
CY2023Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.00 | |
CY2022Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.00 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.00 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.00 | ||
CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
3096783981 | shares |
CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
3096783981 | shares |
CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1867681876 | shares |
CY2022Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1867681876 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
3096783981 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
3096783981 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1867681876 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1867681876 | shares | |
CY2023Q2 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
138468716631 | shares |
CY2022Q2 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
140794298026 | shares |
us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
138468716631 | shares | |
us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
140794298026 | shares | |
CY2023Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
141565500612 | shares |
CY2022Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
142661979902 | shares |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
141565500612 | shares | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
142661979902 | shares | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-7898742 | usd | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-1977777 | usd | |
us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | usd | |
us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | usd | |
us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
0 | usd | |
us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
3823 | usd | |
us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
0 | usd | |
us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
0 | usd | |
us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
0 | usd | |
us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
0 | usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-0 | usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-3823 | usd | |
CY2023Q2 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
7593594 | usd |
CY2023Q2 | BONZ |
Cumulative Net Operating Losses
CumulativeNetOperatingLosses
|
18606451 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
3163097 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
3414101 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
2093063 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
3414101 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
2093063 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | usd |
BONZ |
Management Service Fee
ManagementServiceFee
|
0 | usd | |
BONZ |
Management Service Fee
ManagementServiceFee
|
72500 | usd | |
CY2022Q2 | us-gaap |
Investments
Investments
|
20000000 | usd |
CY2023Q2 | us-gaap |
Contractual Obligation
ContractualObligation
|
19743350 | usd |